Drug interactions
Ertugliflozin-sitagliptin + Exenatide injectable
Severity: Moderate
Ertugliflozin-sitagliptin and Exenatide injectable: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Sitagliptin and exenatide both act on the incretin pathway, so effects are additive and largely redundant. Hypoglycemia is uncommon unless insulin or a sulfonylurea is also being taken. Combined use offers little additional benefit.
What this interaction means in plain words
Ertugliflozin-sitagliptin and Exenatide injectable can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Duplicate incretin-pathway activity from a DPP-4 inhibitor and a GLP-1 receptor agonist.
What to do
Avoid routine combination of a DPP-4 inhibitor with a GLP-1 agonist. If used together, monitor blood glucose and reduce any concurrent insulin or sulfonylurea if needed.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Ertugliflozin-sitagliptin and Exenatide injectable, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Ertugliflozin-sitagliptin
Frequently asked questions
Can I take Ertugliflozin-sitagliptin with Exenatide injectable?
MediHelp rates the interaction as moderate. Ertugliflozin-sitagliptin and Exenatide injectable can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sitagliptin and exenatide both act on the incretin pathway, so effects are additive and largely redundant. Hypoglycemia is uncommon unless insulin or a sulfonylurea is also being taken. Combined use offers little additional benefit.
How serious is the interaction between Ertugliflozin-sitagliptin and Exenatide injectable?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid routine combination of a DPP-4 inhibitor with a GLP-1 agonist. If used together, monitor blood glucose and reduce any concurrent insulin or sulfonylurea if needed.
What other medicines interact with Ertugliflozin-sitagliptin?
MediHelp also lists interactions of Ertugliflozin-sitagliptin with, for example, Albiglutide, Aripiprazole, Asenapine. The full list is on the Ertugliflozin-sitagliptin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
